Literature DB >> 2358707

Cardiovascular dysautonomia in patients with lepromatous leprosy.

P K Shah1, Y K Malhotra, M Lakhotia, A Kothari, S K Jain, S Mehta.   

Abstract

Autonomic functions were studied by six standard tests in 65 patients with lepromatous leprosy and 25 healthy controls. Dysautonomia was observed in 22 patients, all having the disease for more than five years. Associated peripheral neuropathy, judged clinically, was present in all, except one patient. Of the 22 dysautonomic patients, 9 each had mild or moderate dysantonomia and 4 had severe dysautonomia as per the scoring schedule devised by us. Syncope, gustatory sweating and impotence were the symptoms suggestive of dysautonomia. But not all affected patients reported these symptoms. Involvement of the sympathetic system was more frequent than that of the parasympathetic system. Statistically significant abnormality was seen with Atropine ratio, standing 30:15 beat ratio, postural hypotension and sustained hand grip test. Sustained hand grip test was the one which consistently gave abnormal results in all the 22 dysautonomic patients.

Entities:  

Mesh:

Year:  1990        PMID: 2358707

Source DB:  PubMed          Journal:  Indian J Lepr        ISSN: 0254-9395


  3 in total

1.  A very common case become rare: Anesthetic considerations of lepromatous leprosy.

Authors:  Sandeep Sahu; Vipin Goyal; Sanjay Dhiraaj; Kamal Kishore; P K Singh
Journal:  Anesth Essays Res       Date:  2011 Jul-Dec

2.  Regional Anaesthesia Management in a Patient with Leprosy: Rare Case with Rare Application.

Authors:  Muharrem Uçar; Mukadder Şanlı; Ahmet Selim Özkan; Duygu Demiröz; Mehmet Ali Erdoğan; Mahmut Durmuş
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-02-01

3.  Heart rate variability in multibacillar leprosy: Linear and nonlinear analysis.

Authors:  Marcio Clementino de Souza Santos; Luiz Carlos de Lima Silveira; Sílvia Cristina Garcia Moura-Tonello; Alberto Porta; Aparecida Maria Catai; Givago da Silva Souza
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.